Lancet Oncology

Oncology & Cancer

Convection-enhanced delivery of topotecan active in glioblastoma

A subcutaneously implanted, catheter-pump system capable of chronic convection-enhanced delivery (CED) of topotecan is well tolerated and active for patients with recurrent glioblastoma, according to a study published in ...

page 8 from 38